Clinical Biomarkers Market 2024 - By Share, Top Companies, Revenue Outlook And Growth Forecast By 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Clinical Biomarkers Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $46.11 billion In 2028 At A CAGR Of 10.8%.

The clinical biomarkers market size has grown rapidly in recent years. It will grow from $27.66 billion in 2023 to $30.59 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increased prevalence of chronic disease, focus on personalized medicine and targeted therapies, drug development and clinical trials, regulatory support and funding.

The clinical biomarkers market size is expected to see rapid growth in the next few years. It will grow to $46.11 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to expansion of companion diagnostics, focus on early diagnosis and disease prevention, increasing applications in precision oncology and neurodegenerative diseases, growing infectious diseases. Major trends in the forecast period include ai-powered biomarker discovery, machine learning integration, multi-omics integration, technological innovations, key players' partnerships.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp

Clinical Biomarkers Market Major Segments
The clinical biomarkers market covered in this report is segmented -

1) By Offering: Product, Service
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas
4) By Application: Clinical Diagnostic, Translational Research
5) By End User: Contract Research Organizations (CROs), Research and Academic Laboratories, Biopharmaceutical and Biotech Companies, Diagnostic Centers, Other End Users

Key Driver - Surge In Cancer Propels The Clinical Biomarker Market Expansion

High cancer prevalence is expected to propel the growth of the clinical biomarker market going forward. Cancer is a term used to describe a group of disorders in which abnormal cells grow and divide uncontrollably, with the potential to invade and harm healthy bodily tissue. Clinical biomarkers play a crucial role in cancer prevention by aiding in early detection, risk assessment, and monitoring of individuals at high risk for developing cancer. For instance, in May 2021, according to the National Library of Medicine, a US-based medicine library, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020. Therefore, the high cancer prevalence is driving the growth of the clinical biomarker market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12670&type=smp

Prominent Trend - Technological Advancements Reshape Biomarker Market Landscape

Technological advancements are a key trend gaining popularity in the clinical biomarker market. Major companies operating in the clinical biomarker market are developing innovative technologies to sustain their position in the market. For instance, in June 2023, Veravas Inc., a US-based manufacturer of medicinal products for enhancing laboratory medicine, launched VeraBIND (Biomarker Isolation and N-enrichment for Detection) technology. It provides a uniquely innovative and comprehensive approach that enhances the precision of biomarker identification and reduces the likelihood of false positive or negative results across a range of sample types. Clinical laboratories can improve their diagnostic procedures and aid in early disease detection by putting this invention into practice, allowing for prompt and focused interventions. Additionally, VeraBIND paves the path for quicker assay creation, providing precision and consistency in studies, clinical studies, and diagnostic screenings.

Clinical Biomarkers Market Players
Major companies operating in the clinical biomarkers market report are Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the clinical biomakers market in 2023. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Clinical Biomarkers Market Report Structure
3. Clinical Biomarkers Market Trends And Strategies
4. Clinical Biomarkers Market - Macro Economic Scenario
5. Clinical Biomarkers Market Size And Growth
…..
27. Clinical Biomarkers Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.